Health Care & Life Sciences » Biotechnology | Gene Techno Science Co. Ltd.

Gene Techno Science Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
301
61
1,161
1,089
1,060
1,022
Cost of Goods Sold (COGS) incl. D&A
142
15
501
398
423
413
Gross Income
159
45
660
692
637
609
SG&A Expense
672
403
1,480
1,876
1,551
1,414
EBIT
512
358
820
1,184
913
806
Unusual Expense
-
-
-
45
8
38
Non Operating Income/Expense
4
16
34
11
3
11
Interest Expense
-
1
-
3
-
-
Pretax Income
517
374
786
1,222
903
854
Income Tax
3
3
2
2
2
2
Consolidated Net Income
519
377
788
1,225
905
856
Net Income
519
377
788
1,225
905
856
Net Income After Extraordinaries
519
377
788
1,225
905
856
Net Income Available to Common
519
377
788
1,225
905
856
EPS (Basic)
60.04
59.55
75.73
68.50
47.27
43.84
Basic Shares Outstanding
9
6
10
18
19
20
EPS (Diluted)
60.04
59.55
75.73
68.50
47.27
43.84
Diluted Shares Outstanding
9
6
10
18
19
20
EBITDA
512
358
820
1,184
913
805
Non-Operating Interest Income
-
-
-
-
1
-

About Gene Techno Science Co.

View Profile
Address
Wall Annex 502
Sapporo Hokkaido 060
Japan
Employees -
Website http://www.g-gts.com
Updated 07/08/2019
Gene Techno Science Co., Ltd. engages in the research and development of biopharmaceutical products. Its products include antibodies, oligosaccharides, small interfering ribonucleic acids, proteins, and peptides. The company was founded on March 1, 2001 and is headquartered in Sapporo, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.